In materials describing Adamax, values of approximately 984.10 and 1032.23 g/mol appear, attributed respectively to the formulas C₄₄H₆₁N₁₁O₁₃S and C₅₀H₆₉N₁₁O₁₁S. The given figures are consistent with the calculated average molar masses of these formulas. However, they are not independent proof of structure nor the result of analysis of a specific sample. The most important distinction concerns four levels of information: the name Adamax, the declared formula, the proposed structure, and actual measurement data. They should not be treated as interchangeable.
In this article, two formulae from the source material serve as reference points for the calculations. We do not present them as two independently confirmed, official variants of Adamax, nor as a complete list of substances occurring under this name.
What can be determined from the provided material?
The source material compares two empirical formulae, assigns the structure Ac-MEHFPGPAG-OH to the first and an adamantane-related modification to the second. It also contains claims regarding product testing results.
However, no raw spectra, full reports of specific samples, or an unambiguous drawing of the second structure were attached. It is therefore possible to check the consistency of the calculations, but not to confirm the composition of the described materials.
| Type of information | What does it allow to determine? | What does he not confirm on his own? |
|---|---|---|
| Name Adamax | How was the material labelled | Unambiguous structure |
| Molecular formula | Declared numbers of atoms | Their order and connections |
| Sequence with modification description | The proposed peptide structure | Sample identities |
| Calculated mass | The consequence of the adopted formula | Presence of substances in the material |
| mass spectrum | Observed ion signals | Automatically full structure |
Two formulae and their corresponding masses
The following values were calculated from two formulae given in the source material. Molecules without additional counter-ions, water of crystallisation and other components were assumed.
| Calculation parameter | Form A | Form B |
|---|---|---|
| Molecular formula | C₄₄H₆₁N₁₁O₁₃S | C₅₀H₆₉N₁₁O₁₁S |
| Average molar mass | approximately 984.10 g/mol | approximately 1032.23 g/mol |
| Monoisotopic neutral mass | approximately 983.4171 Da | approximately 1031.4899 Da |
| Difference B − A | — | around 48.13 g/mol of average molar mass |
If both formulae are correct, they describe different elemental compositions. This is not a difference in concentration alone nor a simple rounding of the same mass.
However, it does not follow from this that exactly two covalent structures have been confirmed. One formula can correspond to different isomers.
Why is 984.10 not a monoisotopic neutral mass?
The average molar mass uses average atomic masses that take into account the natural isotopic composition. The monoisotopic mass relates to a specific set of isotopes, including ¹²C, ¹H, ¹⁴N, ¹⁶O and ³²S.
Therefore, for formula A we obtain approximately 984.10 g/mol as the average molar mass, but approximately 983.4171 Da as the neutral monoisotopic mass.
This is not a contradiction. They are different quantities. The catalogue figure described as molecular weight does not have to be the value of a single peak expected in the spectrum.
Similarly, g/mol is the unit of molar mass, and Da is the unit of mass of a molecule or ion. Their numbers may be related, but the name of the quantity actually being discussed should be retained.
Does pattern A fit Ac-MEHFPGPAG-OH?
Yes, the atom balance is consistent with this notation assuming standard peptide bonds, N-acetylation and a non-amidated C-terminus. This is computational consistency, not sample identification.
The MEHFPGP sequence corresponds to the Semax peptide backbone. The PubChem record gives the formula C₃₇H₅₁N₉O₁₀S for it. [1]
| Formal balance stage | Change | Result |
|---|---|---|
| Starting point: MEHFPGP with free ends | — | C₃₇H₅₁N₉O₁₀S |
| Extension by Ala and Gly residues | +C₅H₈N₂O₂ | C₄₂H₅₉N₁₁O₁₂S |
| N-acetylation | +C₂H₂O | C₄₄H₆₁N₁₁O₁₃S |
The increase for Ala-Gly takes into account their incorporation into the chain, rather than the simple addition of the formulae of two free amino acids. The rules for the names and structure of amino acid residues are described by the IUPAC–IUB nomenclature. [2]
The conclusion is: the proposed structure has the expected pattern A. It is not possible to reverse this reasoning and assume that every material with this mass must necessarily have this exact sequence.
How to read the sequence Ac-MEHFPGPAG-OH?
Ac denotes the acetyl group at the N-terminus. The letters MEHFPGPAG represent nine residues, and the -OH ending indicates a non-amidated C-terminal carboxyl group in the structural notation convention.
| Position | Symbol | Amino acid residue |
|---|---|---|
| 1 | M | Methionine |
| 2 | E | Glutamic acid |
| 3 | H | Histidine |
| 4 | F | Phenylalanine |
| 5 | P | Proline |
| 6 | G | Glycine |
| 7 | P | Proline |
| 8 | A | Alanine |
| 9 | G | Glycine |
There is no adamantane group in the structure defined in this way. This follows from the full structural record, and not solely from the mass of 984.10 g/mol.
This nine-residue structure should also not be referred to simply as N-acetylated Semax without noting the sequence elongation.
Is „N-Acetyl Semax Amidate” the correct synonym?
This name should not be used as a synonym for Ac-MEHFPGPAG-OH. The designation „Semax Amidate” suggests C-terminal amidation, whereas -OH indicates a carboxylic terminus. Furthermore, Semax on its own denotes the shorter sequence MEHFPGP.
Ac-MEHFPGP-NH₂ and Ac-MEHFPGPAG-OH therefore differ in both chain length and end group.
General similarity of names does not remove these differences. The documentation should present the full sequence and endings instead of treating the names of different derivatives as interchangeable.
What does a difference of around 48 actually mean?
Subtracting formula A from formula B gives the formal balance:
C₅₀H₆₉N₁₁O₁₁S − C₄₄H₆₁N₁₁O₁₃S = +C₆H₈ − O₂
Using average atomic masses, this corresponds to approximately 48.132 g/mol. For monoisotopic masses, the difference is approximately 48.0728 Da.
This balance shows that formula B has more carbon and hydrogen and less oxygen. It is not a description of the reaction mechanism and does not establish the site of modification.
Without complete structures, it cannot be stated that a specific change occurred at the C end, that the entire remaining backbone was preserved, or that B was obtained directly from A.
Is the difference of 48 Da the mass of adamantane?
Adamantane is a cage hydrocarbon with the formula C₁₀H₁₆. [3] From this formula, the average molar mass is approximately 136.24 g/mol.
Therefore, the difference of approximately 48 g/mol is not the mass of the adamantane molecule added without other changes.
Modification using an adamantane derivative may involve the removal of other atoms or groups. To determine its balance, it is necessary to know the actual structures of the substrate and product, the point of attachment and the type of bond.
Mass increase alone does not identify the adamantane cage. Nor does the prefix „adam-” in the name constitute analytical proof.
Does formula B confirm the adamantylated structure?
The formula C₅₀H₆₉N₁₁O₁₁S on its own does not show atomic connections. It does not specify the sequence, the site of modification, or the presence of a specific ring system.
The starting material is assigned an adamantane modification, but an unambiguous structural description and appropriate characterisation are required for independent confirmation of this assignment.
Therefore, we do not present 1032.23 g/mol as automatic proof of „true Adamax”. It is the calculated mass of the specifically declared formula.
What does a mass spectrometer measure?
A mass spectrometer records the mass-to-charge ratio of an ion, m/z. The observed ion may be protonated, deprotonated, multiply charged, form an adduct or constitute a fragment of a larger molecule.
Before comparing the peak with the expected substance, its assignment must be established. The number alone without information about the charge and the type of ion is insufficient.
For protonated ions, one can calculate:
m/z for [M+H]⁺ = M + mass of a proton
m/z for [M+2H]²⁺ = (M + 2 × proton mass) / 2
M stands here for the neutral monoisotopic mass. In the calculations below, a proton mass of approximately 1.007276 Da has been assumed.
| Theoretical ion | Form A | Form B |
|---|---|---|
| [M+H]⁺ | 984,4244 | 1032,4971 |
| [M+2H]²⁺ | 492,7158 | 516,7522 |
These are calculated values, not results obtained for actual samples. Providing them does not guarantee that these exact ions will dominate under specific measurement conditions.
Is the peak around 492.7 a fragment?
It may correspond to the diprotonated ion of the whole molecule corresponding to formula A. In such an assignment, it is [M+2H]²⁺, and not a chain fragmentation product.
However, one should not assign the charge solely based on the approximate number. Among other things, isotopic spacings and the full signal pattern are helpful. For an ion with a 2+ charge, the typical spacing between consecutive isotopic peaks is approximately 0.5 units m/z.
Fragmentation, multiple protonation and adduct formation are distinct phenomena. The original description lumped them together too loosely.
Does mass spectrometry confirm identity?
Mass matching can support compound assignment. It does not automatically resolve the amino acid sequence, spatial configuration, or atomic connectivity.
Isomers can have identical formulae and mass. Furthermore, with insufficient resolution, different compositions can yield similar signals.
For a more complete characterisation, fragmental MS/MS data, comparison with an appropriately characterised reference material, NMR, or other methods addressing a specific ambiguity may be required.
Mass match with A may rule out a simple assignment of the same, correctly identified ion to neutral formula B. It does not, however, identify all sample components or rule out the presence of B below the limit of detection.
Identity, purity and content
Identity answers the question of what relationship was detected. Purity describes the material profile in terms of the method. Content determines the amount of the analyte.
High chromatographic purity does not necessarily mean a high mass fraction of the entire peptide. Water, counterions or components invisible to the detector may not be included in such a result.
Also, the main peak is not an automatically identified compound. Therefore, the statement „99%” without specifying the size and method does not answer the question about the structure.
What information does the evaluation of an analytical report require?
The report should make it possible to link the result to a specific material and research question. The most important things are:
- sample identifier and scope of analysis carried out;
- declared structure, not just the acronym;
- distinction between the expected and measured value;
- method, ion type, charge and spectrum interpretation method;
- supporting data for identification and their limitations;
- personal explanation of purity and content, if indicated.
A document containing only a transcribed formula and a calculated mass is not proof that a measurement was performed. Conversely, the absence of the full spectrum in the abbreviated document does not prove that the analysis was not carried out; it merely limits what the reader can independently assess.
Why don't market commentaries replace a dataset?
Single reports on samples do not establish which material dominates the entire market. Such a conclusion would require a description of the sample selection, their number, dates, methods, and results.
Similarly, the lack of a found report does not prove that a specific structure does not exist or cannot be obtained.
This article does not resolve the frequency of variant occurrences or the authenticity of the products. It analyses the consistency of specific patterns and the scope of possible chemical conclusions.
Frequently asked questions
Do „984” and „1032” refer to two doses?
In the discussed compilation, the numbers refer to approximate molar masses, not doses or concentrations. The two given formulae differ in elemental composition. However, this does not mean that the numerical designations are a full identification of the structures. It is necessary to indicate the formula, end groups and other details that the number itself does not contain.
Does a result of around 984 prove the absence of adamantane?
Mass alone does not allow all structural fragments to be determined. The absence of adamantane results from the specific sequence Ac-MEHFPGPAG-OH, provided such a structure has indeed been confirmed. This conclusion cannot be transferred to every material of a similar mass. Interpretation requires correct ion assignment and additional structural data.
Does a result of around 1032 confirm adamantylation?
Not on its own. The calculated mass of formula B does not represent its atomic connectivity. A consistent signal can support a given hypothesis, but it does not replace the identification of the modification. To indicate an adamantane group, one must have an appropriate reference structure and data allowing to distinguish it from other possible assignments.
Is the difference of about 48 the mass of the attached adamantane?
No. Adamantane has a different mass. The difference between the given formulae is a balance of +C₆H₈−O₂. This notation refers to the number of atoms, not to the mechanism or the site of the reaction. It is not sufficient to reconstruct a specific end-group exchange or other covalent modification.
Why does the value 492.7158 correspond to a much larger molecule?
Because it shows the m/z of a theoretical 2+ ion rather than the neutral molecular mass. In this calculation, the mass along with two protons is divided by two. Such an assignment should be confirmed by the spectral features. The approximate peak position alone does not prove its charge or identity.
Are N-acetylation and amidation the same thing?
No. N-acetylation involves the attachment of an acetyl group at the amino terminus. C-terminal amidation alters the carboxylic terminus. The modifications have different atomic balances and structural significance. They should not be used interchangeably in the name, especially when the compared compounds also differ in sequence length.
Does high purity solve the problem of the Adamax name?
No. Purity and identification answer different questions. A sample may show a dominant signal without full structural confirmation. The name of a material does not become unambiguous by adding a purity percentage. Data linking a specific component to a definite chemical description are needed.
Are the presented calculations a product test?
No. The calculations derive exclusively from two formulae provided in the source material and the adopted atomic masses. No physical sample, raw spectrum, or specific batch documentation was analysed. The results show expected values and inconsistencies in reasoning, but do not confirm the composition of any product.
Disclaimer
The article is of an educational nature and concerns the naming, calculations, and interpretation of chemical data. It does not constitute medical or legal advice, a purchase recommendation, or instructions for the use of substances. The compliance of a formula or mass does not confirm safety or efficacy. We do not evaluate the authenticity of specific products.
This article does not constitute medical or legal advice, does not recommend any specific product, supplier or method of use, and nothing in it should be construed as an encouragement to procure, purchase or use Adamax in any form.
References
[1] NCBI, PubChem. ACTH (4-7), Pro-Gly-Pro- / Semax, CID 9811102. Record and formula C₃₇H₅₁N₉O₁₀S.
[2] IUPAC–IUB Joint Commission on Biochemical Nomenclature. Nomenclature and Symbolism for Amino Acids and Peptides.
[3] NCBI, PubChem. Adamantane, CID 9238. Record and formula C₁₀H₁₆.